Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

John Arcaroli

Concepts (359)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
19
2018
621
2.890
Why?
Xenograft Model Antitumor Assays
20
2018
706
1.590
Why?
Antineoplastic Agents
17
2018
1897
1.500
Why?
Drug Resistance, Neoplasm
7
2016
642
1.180
Why?
Benzodioxoles
3
2012
84
1.100
Why?
Quinazolines
4
2012
243
1.060
Why?
Camptothecin
4
2016
98
0.960
Why?
Receptor, Notch1
3
2015
61
0.910
Why?
Aldehyde Dehydrogenase
6
2017
134
0.890
Why?
Mice, Nude
15
2018
635
0.810
Why?
Haplotypes
4
2012
453
0.800
Why?
Phosphatidylinositol 3-Kinases
9
2018
330
0.720
Why?
Gene Dosage
3
2015
134
0.670
Why?
Wnt Signaling Pathway
4
2015
147
0.640
Why?
src-Family Kinases
3
2017
88
0.630
Why?
Amyloid Precursor Protein Secretases
3
2014
73
0.630
Why?
Protein Kinase Inhibitors
9
2018
796
0.620
Why?
Enzyme Inhibitors
5
2016
752
0.620
Why?
Anilides
2
2018
67
0.620
Why?
Biomarkers, Tumor
9
2018
1054
0.610
Why?
Neutrophils
11
2007
1164
0.600
Why?
Mice
38
2018
14936
0.570
Why?
Endotoxemia
8
2004
82
0.570
Why?
Pancreatic Neoplasms
5
2016
733
0.540
Why?
Acute Lung Injury
2
2011
300
0.540
Why?
Receptors, Notch
2
2015
85
0.540
Why?
Cell Line, Tumor
20
2018
2725
0.530
Why?
Tankyrases
1
2016
14
0.530
Why?
Pyridines
3
2018
425
0.510
Why?
Drug Discovery
1
2016
124
0.510
Why?
Polymorphism, Genetic
3
2007
612
0.490
Why?
3' Untranslated Regions
2
2012
129
0.480
Why?
NF-kappa B
12
2007
637
0.480
Why?
DNA Copy Number Variations
1
2015
159
0.470
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2014
86
0.470
Why?
Proto-Oncogene Proteins c-met
1
2014
69
0.460
Why?
Tetrahydronaphthalenes
1
2013
31
0.430
Why?
Valine
1
2013
72
0.430
Why?
Animals
41
2018
31839
0.420
Why?
Signal Transduction
17
2018
4525
0.390
Why?
Sepsis
3
2007
508
0.390
Why?
Lipopolysaccharides
9
2007
817
0.380
Why?
Superoxide Dismutase
3
2008
305
0.360
Why?
Urokinase-Type Plasminogen Activator
2
2007
28
0.350
Why?
Proto-Oncogene Proteins
7
2018
611
0.340
Why?
Neoplasm Metastasis
4
2016
530
0.340
Why?
Hemorrhage
6
2004
618
0.340
Why?
Interleukins
1
2011
236
0.330
Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
77
0.320
Why?
Cell Proliferation
12
2018
2199
0.320
Why?
Heterografts
3
2018
117
0.310
Why?
HCT116 Cells
4
2018
71
0.300
Why?
SOXB1 Transcription Factors
2
2018
61
0.280
Why?
Mutation
3
2012
3354
0.280
Why?
Azepines
2
2018
74
0.280
Why?
Promoter Regions, Genetic
1
2011
1133
0.280
Why?
Benzimidazoles
3
2013
138
0.280
Why?
Immunoblotting
5
2015
283
0.260
Why?
Apoptosis
10
2018
2371
0.260
Why?
Humans
45
2018
114937
0.250
Why?
beta Catenin
3
2016
220
0.250
Why?
Receptors, Interleukin-1
1
2006
227
0.240
Why?
Neutrophil Activation
5
2003
94
0.240
Why?
TOR Serine-Threonine Kinases
4
2018
359
0.240
Why?
Pyrimidines
2
2018
378
0.240
Why?
Oligonucleotide Array Sequence Analysis
6
2015
744
0.230
Why?
Mitogen-Activated Protein Kinases
6
2014
278
0.230
Why?
Female
24
2018
59581
0.230
Why?
Intracellular Signaling Peptides and Proteins
2
2006
386
0.230
Why?
Aged
11
2016
19122
0.230
Why?
Adrenergic alpha-Antagonists
2
2002
30
0.220
Why?
Colonic Neoplasms
2
2016
222
0.220
Why?
Middle Aged
12
2016
26806
0.210
Why?
Genetic Predisposition to Disease
1
2011
2102
0.210
Why?
Proto-Oncogene Proteins c-akt
7
2018
400
0.210
Why?
Proto-Oncogene Proteins c-raf
1
2002
43
0.210
Why?
Adrenergic alpha-Agonists
1
2002
29
0.210
Why?
Neuroimmunomodulation
1
2002
70
0.200
Why?
ras Proteins
3
2013
138
0.200
Why?
Adrenergic beta-Agonists
1
2002
126
0.190
Why?
Adult
11
2016
30608
0.190
Why?
Adrenergic beta-Antagonists
2
2002
288
0.190
Why?
Mice, Inbred BALB C
9
2003
1153
0.180
Why?
Polymorphism, Single Nucleotide
4
2011
1893
0.180
Why?
Hemoptysis
1
2000
35
0.180
Why?
Head and Neck Neoplasms
2
2016
436
0.180
Why?
In Situ Hybridization, Fluorescence
2
2012
314
0.170
Why?
Cytokines
4
2005
1843
0.170
Why?
Male
22
2016
55663
0.170
Why?
Carcinoma, Squamous Cell
2
2016
584
0.170
Why?
Cell Transformation, Neoplastic
2
2018
312
0.160
Why?
DNA Topoisomerases, Type II
2
2016
44
0.160
Why?
Transplantation, Heterologous
2
2016
183
0.160
Why?
CDC2 Protein Kinase
1
2018
25
0.160
Why?
MAP Kinase Kinase Kinases
2
2015
68
0.150
Why?
Case-Control Studies
3
2011
3008
0.150
Why?
Gene Expression Profiling
4
2018
1523
0.150
Why?
Oncogene Proteins v-abl
1
2017
4
0.150
Why?
Mitogen-Activated Protein Kinase Kinases
3
2010
113
0.150
Why?
Proto-Oncogene Proteins p21(ras)
5
2016
229
0.150
Why?
Dasatinib
1
2017
46
0.150
Why?
Immunohistochemistry
5
2017
1635
0.140
Why?
Antigens, Neoplasm
2
2016
222
0.140
Why?
Adenocarcinoma
2
2014
801
0.140
Why?
Neoplasms
3
2016
2106
0.140
Why?
Angiogenesis Inhibitors
2
2018
215
0.140
Why?
Receptors, Cell Surface
2
2012
354
0.140
Why?
Neovascularization, Pathologic
2
2018
283
0.140
Why?
Cyclic AMP Response Element-Binding Protein
3
2002
127
0.140
Why?
Intercellular Signaling Peptides and Proteins
2
2015
350
0.140
Why?
Corynebacterium
1
2017
36
0.140
Why?
Phosphatidylinositol 3-Kinase
1
2016
27
0.140
Why?
Aged, 80 and over
5
2014
6364
0.140
Why?
Neoplastic Stem Cells
2
2018
334
0.140
Why?
Corynebacterium Infections
1
2017
31
0.140
Why?
Axin Protein
1
2016
18
0.130
Why?
Cell Cycle
5
2018
544
0.130
Why?
Aurora Kinase A
1
2016
52
0.130
Why?
Neoplasms, Experimental
1
2017
152
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2014
1361
0.130
Why?
Transcription Factor 7-Like 2 Protein
1
2016
24
0.130
Why?
Autophagy
1
2018
234
0.130
Why?
RNA, Messenger
5
2016
2559
0.130
Why?
Genotype
3
2012
1775
0.130
Why?
RNA, Small Interfering
2
2015
543
0.130
Why?
Jagged-1 Protein
1
2015
23
0.130
Why?
Serrate-Jagged Proteins
1
2015
28
0.130
Why?
Drug Synergism
2
2014
316
0.130
Why?
Pyrazoles
1
2018
364
0.130
Why?
Gene Duplication
1
2015
63
0.120
Why?
Retinaldehyde
1
2015
6
0.120
Why?
Pyrimidinones
1
2015
88
0.120
Why?
HMGB1 Protein
2
2007
48
0.120
Why?
Respiration, Artificial
2
2011
526
0.120
Why?
Acetaldehyde
1
2015
20
0.120
Why?
Neoplasm Transplantation
4
2016
232
0.120
Why?
Acridines
1
2014
7
0.120
Why?
Topoisomerase II Inhibitors
1
2014
23
0.120
Why?
Pyridones
1
2015
124
0.120
Why?
Gene Expression Regulation
2
2007
2324
0.110
Why?
Cell Cycle Proteins
1
2018
552
0.110
Why?
Benzazepines
1
2014
37
0.110
Why?
Calcium-Binding Proteins
1
2015
207
0.110
Why?
Wnt Proteins
1
2015
135
0.110
Why?
Cellular Senescence
1
2015
153
0.110
Why?
Disease Models, Animal
4
2018
3549
0.110
Why?
Cell Growth Processes
1
2013
51
0.110
Why?
Carcinoma, Pancreatic Ductal
1
2016
212
0.110
Why?
DNA-Binding Proteins
3
2016
1317
0.110
Why?
Tumor Suppressor Proteins
1
2015
282
0.100
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2012
9
0.100
Why?
Molecular Targeted Therapy
1
2015
347
0.100
Why?
Cyclosporine
1
2013
161
0.100
Why?
Random Allocation
1
2013
335
0.100
Why?
p38 Mitogen-Activated Protein Kinases
5
2007
262
0.100
Why?
Gene Knockdown Techniques
1
2013
299
0.100
Why?
Enzyme Activation
6
2003
790
0.100
Why?
Chemokine CXCL12
1
2012
74
0.100
Why?
Aldehyde Dehydrogenase, Mitochondrial
3
2017
33
0.100
Why?
Melanoma
1
2018
631
0.100
Why?
Prognosis
3
2015
3344
0.100
Why?
Receptors, CXCR4
1
2012
78
0.100
Why?
Lung
8
2004
3593
0.100
Why?
Linkage Disequilibrium
2
2012
245
0.100
Why?
Immunoprecipitation
1
2012
152
0.100
Why?
Lung Diseases
3
2004
703
0.100
Why?
Antibodies, Monoclonal, Humanized
2
2013
666
0.100
Why?
Hydroxamic Acids
1
2011
80
0.100
Why?
Peroxidase
2
2002
157
0.090
Why?
Sirolimus
1
2012
181
0.090
Why?
Drug Design
1
2012
151
0.090
Why?
Genetic Markers
1
2012
322
0.090
Why?
PTEN Phosphohydrolase
1
2012
140
0.090
Why?
Genetic Association Studies
1
2012
345
0.090
Why?
Administration, Oral
1
2012
731
0.090
Why?
Histone Deacetylase Inhibitors
1
2011
198
0.090
Why?
Phosphorylation
3
2018
1572
0.090
Why?
Cetuximab
3
2016
91
0.080
Why?
Membrane Proteins
1
2015
1022
0.080
Why?
Cell Separation
1
2010
292
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2016
1148
0.080
Why?
Antibodies, Monoclonal
1
2015
1270
0.080
Why?
G2 Phase Cell Cycle Checkpoints
2
2018
41
0.080
Why?
Models, Statistical
1
2012
604
0.080
Why?
Chemokines
4
2003
213
0.080
Why?
Genetic Variation
2
2012
876
0.070
Why?
Cells, Cultured
6
2007
3897
0.070
Why?
Chemokine CXCL2
3
2001
37
0.070
Why?
Clinical Trials as Topic
2
2015
934
0.070
Why?
Europe
1
2007
336
0.070
Why?
HT29 Cells
2
2018
36
0.070
Why?
Gene Expression
2
2003
1422
0.070
Why?
Flow Cytometry
1
2010
1087
0.070
Why?
ErbB Receptors
3
2016
561
0.070
Why?
Genome, Human
1
2008
352
0.070
Why?
Adolescent
3
2011
17829
0.070
Why?
Thymine
1
2006
12
0.070
Why?
Interleukin-1 Receptor-Associated Kinases
1
2006
20
0.070
Why?
Cytosine
1
2006
45
0.070
Why?
Tumor Burden
2
2018
262
0.070
Why?
MicroRNAs
1
2012
601
0.070
Why?
Phentolamine
2
2002
17
0.060
Why?
Translocation, Genetic
1
2006
94
0.060
Why?
Inflammation Mediators
2
2006
476
0.060
Why?
Homozygote
1
2006
188
0.060
Why?
MAP Kinase Kinase 2
2
2002
27
0.060
Why?
Cell Nucleus
2
2006
554
0.060
Why?
Spheroids, Cellular
2
2016
58
0.060
Why?
Propranolol
2
2002
53
0.060
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
929
0.060
Why?
Survival Analysis
1
2008
1220
0.060
Why?
Models, Biological
2
2018
1630
0.060
Why?
MAP Kinase Kinase 1
2
2002
66
0.060
Why?
Introns
1
2006
227
0.060
Why?
Exons
1
2006
303
0.060
Why?
Heat-Shock Proteins
1
2005
113
0.060
Why?
Mitogen-Activated Protein Kinase 3
2
2002
146
0.060
Why?
Neoplasm Invasiveness
2
2016
445
0.060
Why?
Bone Marrow Cells
2
2003
267
0.060
Why?
Cause of Death
1
2006
363
0.060
Why?
Shock, Septic
1
2006
185
0.060
Why?
Positron-Emission Tomography
2
2018
265
0.060
Why?
Oxidants
1
2003
112
0.050
Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.050
Why?
Brimonidine Tartrate
1
2002
9
0.050
Why?
Models, Genetic
1
2005
565
0.050
Why?
Phenylephrine
1
2002
74
0.050
Why?
Transcription, Genetic
2
2006
1317
0.050
Why?
RNA Interference
2
2016
437
0.050
Why?
Lung Neoplasms
1
2015
2223
0.050
Why?
Hydrogen Peroxide
1
2003
287
0.050
Why?
Quinoxalines
1
2002
60
0.050
Why?
Tumor Necrosis Factor-alpha
3
2004
1134
0.050
Why?
Protein-Tyrosine Kinases
2
2002
399
0.050
Why?
Membrane Glycoproteins
1
2004
429
0.050
Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
130
0.050
Why?
Free Radical Scavengers
1
2001
78
0.050
Why?
MAP Kinase Signaling System
1
2002
276
0.050
Why?
Transcriptome
2
2016
728
0.050
Why?
High Mobility Group Proteins
1
2000
49
0.040
Why?
Nuclear Proteins
2
2001
593
0.040
Why?
Protein Processing, Post-Translational
1
2002
399
0.040
Why?
Neutropenia
1
2000
125
0.040
Why?
Interleukin-1
2
2000
966
0.040
Why?
Adjuvants, Immunologic
1
2000
206
0.040
Why?
Colorado
1
2008
4091
0.040
Why?
Trans-Activators
1
2001
368
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
Why?
Biomarkers
1
2008
3418
0.040
Why?
4-Aminobenzoic Acid
1
2018
6
0.040
Why?
Up-Regulation
2
2016
812
0.040
Why?
Neoplasm Proteins
2
2016
385
0.040
Why?
Pneumonia
1
2003
568
0.040
Why?
Protein Transport
1
2018
396
0.040
Why?
Retinal Dehydrogenase
1
2016
41
0.030
Why?
Inhibitory Concentration 50
1
2016
75
0.030
Why?
Prospective Studies
1
2007
6218
0.030
Why?
Hyaluronan Receptors
1
2016
91
0.030
Why?
Blotting, Western
2
2013
1151
0.030
Why?
Young Adult
1
2011
10478
0.030
Why?
Protein Interaction Maps
1
2016
34
0.030
Why?
Tissue Array Analysis
1
2016
50
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
107
0.030
Why?
Papillomaviridae
1
2016
102
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
180
0.030
Why?
Chromatin Immunoprecipitation
1
2016
129
0.030
Why?
Cadherins
1
2016
176
0.030
Why?
S-Phase Kinase-Associated Proteins
1
2015
18
0.030
Why?
Inflammation
1
2005
2485
0.030
Why?
Diphenylamine
1
2014
6
0.030
Why?
Iloprost
1
2015
46
0.030
Why?
Acid Phosphatase
1
2014
17
0.030
Why?
Rhodamines
1
2014
17
0.030
Why?
Retrospective Studies
1
2011
12544
0.030
Why?
Tumor Cells, Cultured
1
2016
855
0.030
Why?
G2 Phase
1
2014
31
0.030
Why?
Cell Division
1
2016
759
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
271
0.030
Why?
Epithelial-Mesenchymal Transition
1
2016
168
0.030
Why?
Mice, Inbred C57BL
3
2015
4719
0.030
Why?
Sequence Analysis, RNA
1
2016
390
0.030
Why?
Antigens, CD
1
2016
443
0.030
Why?
Benzamides
1
2014
169
0.030
Why?
Tretinoin
1
2015
125
0.030
Why?
Transfection
1
2016
870
0.030
Why?
Receptor, Notch2
1
2013
14
0.030
Why?
Gonanes
1
2013
27
0.030
Why?
Protein Binding
1
2018
1897
0.030
Why?
Alphapapillomavirus
1
2013
36
0.030
Why?
Receptors, CXCR
1
2012
2
0.030
Why?
Tumor Suppressor Protein p53
1
2016
447
0.030
Why?
Erlotinib Hydrochloride
1
2012
65
0.030
Why?
Cyclin D1
1
2012
61
0.030
Why?
Disease-Free Survival
1
2014
623
0.030
Why?
Active Transport, Cell Nucleus
2
2003
110
0.030
Why?
Mice, Knockout
3
2003
2587
0.030
Why?
Computers
1
2012
60
0.030
Why?
Mice, Inbred C3H
2
2004
242
0.020
Why?
Niacinamide
1
2012
64
0.020
Why?
Maximum Tolerated Dose
1
2012
184
0.020
Why?
Tissue Distribution
1
2012
285
0.020
Why?
Phenylurea Compounds
1
2012
84
0.020
Why?
United States
1
2007
12211
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
115
0.020
Why?
Calcium Signaling
1
2013
213
0.020
Why?
Injections, Intraperitoneal
2
2001
100
0.020
Why?
Xanthine Oxidase
2
2001
71
0.020
Why?
Acute Disease
2
2004
915
0.020
Why?
Cluster Analysis
1
2011
460
0.020
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
238
0.020
Why?
Survival Rate
1
2014
1644
0.020
Why?
Ligands
1
2011
565
0.020
Why?
Vascular Endothelial Growth Factor A
1
2012
499
0.020
Why?
Models, Molecular
1
2014
1379
0.020
Why?
Tumor Microenvironment
1
2012
434
0.020
Why?
Computational Biology
1
2013
531
0.020
Why?
Dose-Response Relationship, Drug
1
2012
1856
0.020
Why?
Cell Movement
1
2011
867
0.020
Why?
Adiposity
1
2012
457
0.020
Why?
Calcium
1
2013
1104
0.020
Why?
Mice, Transgenic
2
2003
1953
0.020
Why?
Magnetic Resonance Imaging
1
2018
3053
0.020
Why?
Oxidative Stress
2
2003
1084
0.020
Why?
Neutrophil Infiltration
1
2004
94
0.010
Why?
Permeability
1
2004
148
0.010
Why?
Transcription Factor AP-1
1
2003
80
0.010
Why?
Algorithms
1
2010
1474
0.010
Why?
Phosphotransferases
1
2003
25
0.010
Why?
Reproducibility of Results
1
2010
2770
0.010
Why?
Toll-Like Receptors
1
2004
166
0.010
Why?
Aconitate Hydratase
1
2003
16
0.010
Why?
JNK Mitogen-Activated Protein Kinases
1
2003
144
0.010
Why?
Lipid Peroxidation
1
2003
139
0.010
Why?
Extracellular Space
1
2003
117
0.010
Why?
Metalloporphyrins
1
2003
104
0.010
Why?
Replication Protein C
1
2001
4
0.010
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2001
11
0.010
Why?
Biological Transport
1
2003
372
0.010
Why?
bcl-X Protein
1
2001
38
0.010
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2001
22
0.010
Why?
Cysteine Endopeptidases
1
2001
60
0.010
Why?
Protein Kinases
1
2003
307
0.010
Why?
CREB-Binding Protein
1
2001
27
0.010
Why?
Toll-Like Receptor 4
1
2004
286
0.010
Why?
Transcription Factor RelA
1
2001
83
0.010
Why?
Tungsten
1
2001
26
0.010
Why?
Proto-Oncogene Proteins c-fos
1
2001
164
0.010
Why?
Animal Feed
1
2001
49
0.010
Why?
Immune Sera
1
2000
79
0.010
Why?
Proto-Oncogene Proteins c-bcl-2
1
2001
213
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2001
164
0.010
Why?
Organ Specificity
1
2000
270
0.010
Why?
Protein Biosynthesis
1
2001
385
0.010
Why?
Endotoxins
1
2000
204
0.010
Why?
Antioxidants
1
2003
530
0.010
Why?
Intubation, Intratracheal
1
2000
215
0.010
Why?
Treatment Outcome
1
2010
9105
0.010
Why?
Peptides
1
2001
848
0.010
Why?
Proteins
1
2001
912
0.010
Why?
Arcaroli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)